X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (399) 399
Journal Article (155) 155
Publication (15) 15
Book / eBook (12) 12
Book Chapter (5) 5
Magazine Article (3) 3
Dissertation (2) 2
Book Review (1) 1
Compact Disc (1) 1
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (260) 260
hygiene (260) 260
medical or veterinary science (260) 260
preparations for medical, dental, or toilet purposes (260) 260
chemistry (193) 193
metallurgy (189) 189
basic electric elements (115) 115
electricity (115) 115
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (108) 108
compounds thereof (96) 96
inorganic chemistry (96) 96
non-metallic elements (96) 96
general tagging of cross-sectional technologies spanning over several sections of the ipc (92) 92
general tagging of new technological developments (92) 92
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (92) 92
capacitors (89) 89
capacitors, rectifiers, detectors, switching devices orlight-sensitive devices, of the electrolytic type (89) 89
technologies or applications for mitigation or adaptation againstclimate change (81) 81
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (79) 79
organic chemistry (76) 76
specific therapeutic activity of chemical compounds ormedicinal preparations (69) 69
peptides (65) 65
humans (63) 63
indexing scheme relating to structural and physical aspects ofsolid inorganic compounds (48) 48
compositions based thereon (44) 44
organic macromolecular compounds (44) 44
their preparation or chemical working-up (44) 44
index medicus (41) 41
performing operations (40) 40
transporting (40) 40
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (38) 38
female (34) 34
technical subjects covered by former us classification (34) 34
technical subjects covered by former uspc (34) 34
climate change mitigation technologies related totransportation (30) 30
pharmacology & pharmacy (30) 30
male (29) 29
after-treatment not covered by subclasses c08b, c08c, c08f,c08g (24) 24
general processes of compounding (24) 24
working-up (24) 24
aged (23) 23
middle aged (22) 22
animals (20) 20
chemical or physical processes, e.g. catalysis or colloidchemistry (17) 17
physical or chemical processes or apparatus in general (17) 17
their relevant apparatus (17) 17
chemistry, medicinal (16) 16
compositions of macromolecular compounds (16) 16
chemistry, multidisciplinary (15) 15
climate change mitigation technologies in the production orprocessing of goods (15) 15
adult (14) 14
analysis (13) 13
chemistry, pharmaceutical (13) 13
drug stability (13) 13
manufacture or treatment of nanostructures (13) 13
measurement or analysis of nanostructures (13) 13
nanotechnology (13) 13
physics (13) 13
specific uses or applications of nanostructures (13) 13
microbiology (12) 12
cables (11) 11
conductors (11) 11
insulators (11) 11
selection of materials for their conductive, insulating ordielectric properties (11) 11
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (11) 11
freeze drying (10) 10
investigating or analysing materials by determining theirchemical or physical properties (10) 10
measuring (10) 10
protein (10) 10
proteins (10) 10
research (10) 10
testing (10) 10
aggregation (9) 9
beer (9) 9
biochemistry (9) 9
compositions thereof (9) 9
culture media (9) 9
enzymology (9) 9
microorganisms or enzymes (9) 9
mutation or genetic engineering (9) 9
oncology (9) 9
propagating, preserving or maintaining microorganisms (9) 9
spirits (9) 9
stability (9) 9
surgery (9) 9
vinegar (9) 9
wine (9) 9
after-treatment of the shaped products, e.g. repairing (8) 8
cancer (8) 8
follow-up studies (8) 8
medicine & public health (8) 8
risk (8) 8
shaping of material in a plastic state, not otherwise providedfor (8) 8
shaping or joining of plastics (8) 8
time factors (8) 8
treatment outcome (8) 8
use of inorganic or non-macromolecular organic substances ascompounding ingredients (8) 8
working of plastics (8) 8
working of substances in a plastic state, in general (8) 8
aged, 80 and over (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
UTL at Downsview - May be requested (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Faculty of Information - Oversize (1) 1
Gerstein Science - Stacks (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
Music - Circulation Desk (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Rare Book (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Oversize (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (548) 548
French (146) 146
German (47) 47
Chinese (16) 16
Korean (10) 10
Spanish (9) 9
Italian (7) 7
Norwegian (7) 7
Portuguese (6) 6
Danish (2) 2
Greek (2) 2
Japanese (2) 2
Slovenian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2004, Biotechnology, ISBN 0971176760, Volume 2., xxx, 686
Book
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1183 - 1192
Summary Background We studied the effect on tumour response to neoadjuvant therapy of the substitution of lapatinib for trastuzumab in combination with weekly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | WOMEN | CELLS | SURGICAL ADJUVANT BREAST | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | GW572016 | CHEMOTHERAPY PLUS TRASTUZUMAB | PERTUZUMAB | INHIBITOR | DOCETAXEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | United States | Humans | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Breast Neoplasms - enzymology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Mastectomy | Female | Neoadjuvant Therapy | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Drug Administration Schedule | Logistic Models | Treatment Outcome | Chi-Square Distribution | Breast Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Quinazolines - adverse effects | Trastuzumab | Health maintenance organizations | Neoadjuvant therapy | Medical colleges | Care and treatment | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Breast cancer | Product development | Public health | Cancer | Index Medicus
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2007, Volume 337, Issue 1, pp. 1 - 24
Interest in intranasal (IN) administration as a non-invasive route for drug delivery continues to grow rapidly. The nasal mucosa offers numerous benefits as a... 
Intranasal drug delivery | Pharmacokinetics | Nasal mucosa | Physicochemical properties | IN-VIVO BIOAVAILABILITY | DEPENDENT DIABETIC-PATIENTS | DIMETHYL-BETA-CYCLODEXTRIN | DIFFERENT MOLECULAR-WEIGHTS | NORKETAMINE PLASMA-CONCENTRATIONS | intranasal drug delivery | physicochemical properties | pharmacokinetics | nasal mucosa | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | ACUTE CHILDHOOD SEIZURES | CSF FOLLOWING INTRANASAL | NASAL DRUG-DELIVERY | WATER-SOLUBLE COMPOUNDS | Cholinesterase Inhibitors - pharmacokinetics | Hypnotics and Sedatives - chemistry | Central Nervous System - metabolism | Molecular Weight | Humans | Vaccines - pharmacokinetics | Cholinesterase Inhibitors - chemistry | Hypnotics and Sedatives - administration & dosage | Antiemetics - administration & dosage | Analgesics - pharmacokinetics | Antiemetics - pharmacokinetics | Inflammation - metabolism | Vaccines - chemistry | Cardiovascular Agents - pharmacokinetics | Drug Compounding | Antiemetics - chemistry | Nasal Mucosa - metabolism | Cardiovascular Agents - administration & dosage | Drug Administration Schedule | Hypnotics and Sedatives - pharmacokinetics | Drug Stability | Solubility | Analgesics - administration & dosage | Administration, Intranasal | Chemistry, Pharmaceutical | Carrier Proteins - metabolism | Cholinesterase Inhibitors - administration & dosage | Analgesics - chemistry | Hydrophobic and Hydrophilic Interactions | Vaccines - administration & dosage | Cardiovascular Agents - chemistry
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 04/2010, Volume 2010, Issue Issue 1, pp. 151 - 158
Pinky Agarwal1, Alida Griffith1, Henry R Costantino2, Narendra Vaish31Booth Gardner Parkinson’s Center, Kirkland, WA, USA; 2Costantino Consulting,... 
Journal Article
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 05/2010, Volume 6, pp. 151 - 158
Restless legs syndrome (RLS) is a sleep-related movement disorder commonly involving an unpleasant urge to move the limbs, typically the legs. Dopaminergic... 
Journal Article
BMC Neuroscience, 12/2008, Volume 9, Issue 3
Journal Article
Drug Development Research, ISSN 0272-4391, 05/2008, Volume 69, Issue 3, pp. 143 - 152
Insulin is the most effective therapy for lowering glycosylated hemoglobin (A1c) levels in Type 2 diabetics, and yet it is typically the last therapeutic... 
Type 2 diabetes | postprandial hyperglycemia | intranasal insulin | Intranasal insulin | Postprandial hyperglycemia | INHALED INSULIN | GLYCEMIC CONTROL | CHEMISTRY, MEDICINAL | DOSE-RESPONSE | HEALTHY-SUBJECTS | DRUG-DELIVERY | MELLITUS | COMPARATIVE TRIAL | INTESTINAL-ABSORPTION | THERAPY | GLARGINE | PHARMACOLOGY & PHARMACY
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 03/2002, Volume 54, Issue 3, pp. 301 - 313
Journal Article
NEUROPSYCHIATRIC DISEASE AND TREATMENT, ISSN 1178-2021, 2010, Volume 6, Issue 1, pp. 151 - 158
Restless legs syndrome (RLS) is a sleep-related movement disorder commonly involving an unpleasant urge to move the limbs, typically the legs. Dopaminergic... 
SYNDROME SYMPTOMS | AMINOMETHYL)-1-CYCLOHEXANE ACETIC-ACID | PSYCHIATRY | restless legs syndrome | CROSS-OVER | XP13512 | CLINICAL NEUROLOGY | NEUROPATHIC PAIN | movement disorder | B RECEPTORS | DOUBLE-BLIND | HEMODIALYSIS-PATIENTS | AGENT GABAPENTIN | gabapentin enacarbil | CALCIUM-CHANNEL | Restless legs syndrome | Expert Opinion
Journal Article